Schrödinger, Inc.
General ticker "SDGR" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $1.6B (TTM average)
Schrödinger, Inc. does not follow the US Stock Market performance with the rate: -9.9%.
Estimated limits based on current volatility of 2.3%: low 17.25$, high 18.07$
Factors to consider:
- Total employees count: 891 (+2.8%) as of 2024
- US accounted for 55.3% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Operational and conduct risks, Cybersecurity threats, Software defects, Geopolitical risks, Acquisition/divestiture risks
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [10.67$, 23.76$]
- 2025-12-31 to 2026-12-31 estimated range: [9.43$, 21.11$]
Financial Metrics affecting the SDGR estimates:
- Negative: with PPE of -7.6 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -11.06 <= 0.04
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: 42.53 < Shareholder equity ratio, % of 51.19 <= 64.17
- Positive: Inventory ratio change, % of -14.43 <= -0.76
Short-term SDGR quotes
Long-term SDGR plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $180.96MM | $216.67MM | $207.54MM |
| Operating Expenses | $327.77MM | $394.11MM | $416.83MM |
| Operating Income | $-146.82MM | $-177.45MM | $-209.30MM |
| Non-Operating Income | $-2.31MM | $220.37MM | $23.59MM |
| R&D Expense | $126.37MM | $181.77MM | $201.78MM |
| Income(Loss) | $-149.12MM | $42.92MM | $-185.71MM |
| Taxes | $0.06MM | $2.20MM | $1.41MM |
| Profit(Loss)* | $-149.19MM | $40.72MM | $-187.12MM |
| Stockholders Equity | $447.89MM | $548.56MM | $421.44MM |
| Assets | $688.59MM | $802.96MM | $823.23MM |
| Operating Cash Flow | $-119.68MM | $-136.73MM | $-157.37MM |
| Capital expenditure | $8.01MM | $13.40MM | $7.31MM |
| Investing Cash Flow | $90.02MM | $193.03MM | $148.84MM |
| Financing Cash Flow | $2.11MM | $9.05MM | $10.12MM |
| Earnings Per Share** | $-2.10 | $0.57 | $-2.57 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.